Member Info for urbansea89

Open goal for Omega. Surely even they can’t **** this one up now.

You’re completely right EnergyShares but it’s a case of restoring trust and what we can believe from them.
It’s not just Als misgivings but the performance of the entire board and the non execs. Currently they all look like a total bunch of ninnies.

It’s a total shambles in comms. We were clearly told the Affidx worked on the the new variant and now apparently it doesn’t. So why say it did in the first place? Forget the rest of the bull****, it either does or it doesn’t.

So many have wasted time and energy with emails to the press and their MPs. Avacta were even raised in the Commons a few days ago. Now this clown says it doesn’t work, having previously said it did. I’m trying my hardest to see anything good out of all this but it’s really hard now to believe anything we’re told. It’s all pretty pathetic.

Just watched it all. Great job Neil Harvey. Disgusted to listen to Ellis afterwards. He personifies everything that is so repugnant about these pigs we elected. I hope they all go to hell.

Merry Christmas all and thanks for so many amazing posts this year.

Totally fair question which I’m certain is on all of our minds.
LFT contracts going right way I reckon £4/£6, or more if unexpected scale up through Medusa eg USA.
AVA success to next stage £15- £25 in 6-12 months.
Exit in 2 years if therapeutics work out at top side est £40-£60

Best news for a long time. Congrats all. Very happy Christmas

Impressive numbers considering all the logistics issues that needed overcoming. Going the right way and so steady. Well done all

It's exceptionally good news from the FDA. Early trial stages must have been very positive.
Hugely exciting times ahead.

Unfortunately this perpetuates the show for certain posters. The skilful way in which they post plausible downers on the stock works well, serves their agenda they know it. It happens across virtually every aim and is a continual blur on the real function of the board. (They say it provides balance, which it doesn’t)
The best response is always no response.
I think we all know deep down that this stock is ultimately destined for great things, despite the bumpy road and will ultimately prove to be a great success.

Roundhowe, I sympathise. I had a similar horrific experience with Xpress Test at the airport a few months ago. This was inside the terminal and was staffed by Easy Jet stewards. It was quite like a chaotic episode of The Apprentice; manic and disorganised. The supposed PCR tests were wrong and I evidenced that at significant cost and hassle.

This Company does my head in but I will be doubling my stake in the coming week. Always held and will continue to. I don’t really think it is 2 pronged, with a proper diagnostics business. I don’t think their heart has really been there and they don’t have the temperament the cut and thrust scale, logistics and politics. I get the felling that science and manufacturing are at odds.
I do however think that the therapeutics business could be the best punt I’ll ever have and I think what they’re doing is extremely clever.

I do agree. The numbers were notably up today.
I note PL75’s sensible post earlier today, recognising the ‘not to be sniffed at’ numbers. This is very true and taking a frugal view on the business. It doesn’t take much to provide easy going revenue streams to make our business quite appealing and more than wash its face.
I keep re reading the research material on therapeutics and, if any of this comes off, it is quite mesmerising. One couldn’t honestly put a figure on valuation. Feet on the ground for just now. Step by step but it could be completely real. Valuations go out of the windows if it goes all the way. Might take some time still but time passes quickly, as we all know.

Good thread Poirot. Radiagreen, think you’re right. Would seem inevitable that LG would be our eventual acquisitor.
LG is my my most positive feeling about progress for us in terms of speed to market. It’s appears to be a great relationship for 3 main reasons: they potentially prove our worth, pay us along the way and then exit us.

Was dreading this presentation but decided to tune in. So much better than previous ones. A lot more honest and robust in delivery. No surprises on AffidX other than it is selling and is likely to increase and more than support the cash position for some time to come. Clearly AVA6000 is going the right way, for now, which is by far the most telling takeaway. My bet also on LG to kick things off in a big way aswell.

I’m really not looking forward to hearing what he has to say tomorrow, sometimes it’s cringe full. Don’t think I’ll tune in.
Have lost a good deal of respect. I don’t think they are comfortable or have the nous with scale and LF type issues and politics, it’s not them. I do however still think it’s an exceptional business and transformational. Great release this morning and is better and more worthwhile than the wild wild West of LFs would ever be long term. Money in the bank and solid growing recognition.
I’m more keen than ever and happy to wait for the amazing chemistry to get the Nobel prize, despite the CEOs weaknesses in certain areas.

I’d be interested to know what the test supplier breakdown is of the daily test numbers. Yesterday was 1,123,798 uk tests. The daily test number doesn’t seem to be reducing radically. Looks similar to back in April. Appreciate many will be PCR but it’s still a big number overall and it’s warm and sunny.

And that’s all we need for now Timster, thanks. Good concise summary. Onwards and upwards I’m sure.

With you on that. Think Roche Holdings is 300B MC

Announcing a new comms channel is only any good if you then use it and have sufficient content that you’re willing to publish, otherwise it simply provokes more dissent. I do hope they will be reasonably active with this over the coming weeks.